You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK)子公司廣藥總院通過高新技術企業重新認定
格隆匯 03-05 18:52

格隆匯3月5日丨白雲山(00874.HK)公告,近日,廣州白雲山醫藥集團股份有限公司(以下簡稱“公司”)子公司廣州醫藥研究總院有限公司(以下簡稱“廣藥總院”)已通過高新技術企業重新認定,並收到由廣東省科學技術廳、廣東省財政廳、國家稅務總局廣東省稅務局聯合頒發的《高新技術企業證書》。

廣藥總院通過高新技術企業認定後,根據國家的相關規定,自獲得高新技術企業認定後連續三年內(2024年、2025年和2026年)可享受國家關於高新技術企業的相關優惠政策,即按15%的稅率繳納企業所得稅。2024年本公司已按照15%的所得稅稅率計繳該公司所得稅。本次廣藥總院獲得《高新技術企業證書》不會對本公司當期經營業績產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account